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Verapamil potentiation of doxorubicin resistance develop-
ment in B16 melanoma cells both in vitro and in vivo.
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Page 346 -
The last line of paragraph two of the discussion was
incorrect. The paragraph should read:
It is interesting to note that cells selected by DX plus
VRP, besides being more resistant compared to those
selected by DX alone, developed features associated with
more differentiated cells. In fact, in vitro they showed
marked cell-substrate adhesiveness, higher melanin content
and a higher number of dendrite-like structures, which are
all characteristic markers of normal differentiating melano-
cytes (Hirobe, 1978). Similar observations of normalization
of cell morphology have been previously reported by DX
alone on B16 melanoma cell lines (Raz, 1982) and on other
cell lines made resistant to daunomycin, vincristine and
actinomycin D (Biedler et al., 1975). In vivo the B16-
DX.VRP line was slightly less tumorigenic and, as previously
reported for B16VDXR, a B16 melanoma line resistant to
DX both in vitro and in vivo (Formelli et al., 1986), it
showed a longer and more heterogeneous latency compared
to B16. Moreover, similar to the B16VDXR line (Formelli et
al., 1986), the B16-DX.VRP line produced a significantly
lower number of metastases compared to the original B16
tumour. Therefore, the results reported here and previously
(Formelli et al., 1986) show that selection by DX both in
vitro (B16VDXR line) and in vivo with the addition of VRP
(B16-DX.VRP line) leads to cells with diminished metastatic
potential. A similar observation of decreased metastases in a
B16-BL6 line made resistant to DX in vitro was recently
reported (Ganapathi et al., 1987).
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